双歧三联活菌片联合蒙脱石散对腹泻患儿预后的影响
Effect of bifid triple viable tablets combined with montmorillonite powder in the prognosis of children with diarrhea
宋晓彤1
作者信息
- 1. 江苏省徐州市中心医院 儿童诊疗中心,江苏 徐州 221000
- 折叠
摘要
目的 探究双歧三联活菌片联合蒙脱石散对腹泻患儿预后的影响.方法 选择江苏省徐州市中心医院儿童诊疗中心2015年10月~2016年12月100例腹泻患儿,采取随机分组的方式,分为对照组与观察组,各50例.对照组采取双歧三联活菌片治疗,观察组采取双歧三联活菌片联合蒙脱石散治疗,对比2组患儿各项指标情况及治疗效果.结果 观察组患儿各项指标情况均优于对照组,差异具有统计学意义(P<0.05).观察组患儿治疗总有效率(98.00%)明显高于对照组(78.00%),差异具有统计学意义(P<0.05).结论 采用双歧三联活菌片联合蒙脱石散治疗腹泻患儿,能够有效改善患儿预后情况,且加快了患儿症状缓解时间,值得应用.
Abstract
Objective To study the effect of Bifid Triple Viable tablets combined with montmorillonite powder in the prognosis of children with diarrhea.Methods100 cases of diarrhea patients from October 2015 to December 2016 were selected.The patients were divided into control group and observation group.The control group was treated with Bifid Triple Viable tablets.The observation group was treated with Bifid Triple Viable tablets combined with montmorillonite powder treatment, compared the two groups of patients with the indicators and treatment.ResultsThe indexes of the observation group were better than the control group, the difference between the groups were statistically significant (P<0.05).The total effective rate (98.00%) in the observation group, which was significantly higher than that in the control group (78.00%), the difference between the groups were statistically significant(P<0.05).ConclusionThe combination of Bifid Triple Viable tablets combined with montmorillonite powder in the treatment of diarrhea patients can effectively improve the prognosis of patients and accelerate the remission time of patients, which is worth applying.
关键词
双歧三联活菌片/蒙脱石散/腹泻/预后Key words
bifid triple viable tablets/montmorillonite powder/diarrhea/prognosis引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据